Last reviewed · How we verify
Ofloxacin 400mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ofloxacin 400mg (Ofloxacin 400mg) — Indiana University School of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ofloxacin 400mg TARGET | Ofloxacin 400mg | Indiana University School of Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ofloxacin 400mg CI watch — RSS
- Ofloxacin 400mg CI watch — Atom
- Ofloxacin 400mg CI watch — JSON
- Ofloxacin 400mg alone — RSS
Cite this brief
Drug Landscape (2026). Ofloxacin 400mg — Competitive Intelligence Brief. https://druglandscape.com/ci/ofloxacin-400mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab